Diagnostic Medical Systems S.A. (FRA:DMS1)

Germany · Delayed Price · Currency is EUR

0.8100

-0.0100 (-1.22%)

Last updated: Oct 23, 2026, 8:07 AM CEST

Market Cap	23.43M -34.0%
Revenue (ttm)	51.41M +3.9%
Net Income	447.00K
EPS	0.02
Shares Out	n/a
PE Ratio	50.40
Forward PE	39.05
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,326
Open	0.8100
Previous Close	0.8200
Day's Range	0.8100 - 0.8100
52-Week Range	0.7800 - 1.5900
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 16, 2026

About FRA:DMS1

Diagnostic Medical Systems S.A. designs, develops, manufactures, and sells medical imaging systems in France. The company offers ADAM, a software suite for imaging experts; R and F solutions, including Platinum Neo, Platinum Flex, and Optima; bone densitometers, including Stratos and Medix Series; MISTRAL, a manual chest and bone solution; and Camargue series which offers motorized radiographic systems to perform all types of bone and chest exams, including full spine and long leg exams. It also provides mobiles under the !M1, ONYX, Rafale/Rafa... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1979

Employees 136

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol DMS1

Financial Performance

In 2025, FRA:DMS1's revenue was 52.86 million, an increase of 8.19% compared to the previous year's 48.86 million. Losses were -167,000, -94.20% less than in 2024.

Financial Statements